Introduction
Met and Ron belong to a family of tyrosine kinase receptors for which Met is the prototype (Comoglio and Boccaccio, 1996) . The Met and Ron ligands, also known as Scatter Factors, are Hepatocyte Growth Factor (HGF) and Macrophage Stimulating Protein (MSP), respectively. In epithelial cells, upon receptor binding, HGF and MSP elicit`invasive growth', a complex genetic program which results from the integration of dierent responses including cell-cell dissociation (`scattering'), growth and invasion of extracellular matrices (Zarnegar and Michalopoulos, 1995; Medico et al., 1996) .
The Met receptor family have distinguishing features: (i) a heterodimeric structure with an extracellular a-subunit disulphide-linked to a transmembrane b-subunit endowed with tyrosine kinase activity (Giordano et al., 1989) ; (ii) two adjacent tyrosine residues in the kinase domain of the b-chain that up-regulate the catalytic activity upon phosphorylation (Longati et al., 1994) ; (iii) a two-tyrosine multifunctional`docking site' in the C-terminal tail of the b-subunit that mediates high-anity interactions with multiple SH2-containing signal transducers. These include Grb2/Sos complex, the p85 subunit of PI-3-kinase, PLC-g , STAT-3 (Boccaccio et al., 1998) and the multiadaptor protein Gab1 (Weidner et al., 1996) . The latter is the major substrate for Met, and its coupling to the receptor docking site via Grb2 correlates with Met-induced transforming potential .
The Met receptor is expressed mainly in epithelial cells (Stoker et al., 1987; Di Renzo et al., 1991) , but it has also been identi®ed in endothelial cells (Bussolino et al., 1992; Grant et al., 1993) , in myoblasts (Anastasi et al., 1997) , in cells of the hematopoietic system (Galimi et al., 1994; Nishino et al., 1995) and in spinal motor neurons (Ebens et al., 1996) . Inappropriate activation of the HGF/Met pathway has been implicated in the onset and progression of a number of tumors and has been shown to promote the metastatic spread of neoplastic cells (Di Renzo et al., 1991 Vande Woude et al., 1997; Giordano et al., 1997) . A more direct link between Met and cancer has been provided by the identi®cation of point mutations in the MET proto-oncogene in hereditary and sporadic papillary renal carcinomas (PRC mutations) . The Met-PRC mutants are constitutively activated and are responsible for foci formation in vitro and tumorigenesis in nude mice . However, uncoupling signal transducers from these oncogenic mutants abrogates the transforming activity and invasive growth . Moreover, mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists .
Ron is expressed in cells of dierent origin: epithelial cells (Gaudino et al., 1994; Medico et al., 1996) , neuroendocrine cells (Gaudino et al., 1995) , osteoclasts (Kurihara et al., 1996) and hematopoietic cells (Banu et al., 1996; Iwama et al., 1996) . Its overexpression in a signi®cant fraction of primary breast carcinomas suggests a correlation with progression of mammary tumors (Maggiora et al., 1998) . The expression of both Ron and its ligand, MSP, in a number of non-small-cell lung carcinomas has been reported, suggesting that an autocrine-paracrine system may be involved in the pathogenesis of lung cancer (Willett et al., 1998) . The MET-PRC mutations reproduced in the Ron kinase confer to the receptor the ability to induce oncogenic and metastatic potential (Santoro et al., 1998; Williams et al., 1999) .
Homo-dimerization is a mechanism which regulates the activation of tyrosine kinase receptors (Heldin, 1995) . Several ligand receptors, including Platelet Derived Growth Factor, Epidermal Growth Factor and Stem Cell Factor, induce stable receptor dimerization by simultaneously binding two monomers. Ligand-bindings induce conformational changes in the receptors which promote receptor-receptor interactions (Westermark and Heldin, 1989; Kanakaraj et al., 1991; Lemmon and Schlessinger, 1994; Blechman and Yarden, 1995) . Dimerization is followed by activation of the tyrosine kinase receptor by intermolecular phosphorylation events. These occur on conserved tyrosines endowed with kinase upregulation properties within the kinase domain. In Met and Ron, two neighboring tyrosines (in Met: Y1234/Y1235 and in Ron: Y1238/Y1239), localized in the activation loop of the kinase domain, are the major phosphorylation sites regulating catalytic activity (Longati et al., 1994) . Other phosphorylation sites correspond to tyrosine residues located outside the kinase domain and have the important function of creating docking sites for SH2-containing molecules. In Met and Ron, two tyrosines in the tail (in Met: Y1349/Y1356 and in Ron Y1353/Y1360) are part of the multifunctional docking site responsible for association with signal transducers Iwama et al., 1996) .
In some cases, formation of heterodimeric complexes allows interaction and cross-talk between dierent receptors of the same subfamily. Heterodimerization occurs among members of the insulin, EGF and PDGF receptor families (Kokai et al., 1989; Kelly et al., 1991; Tartare et al., 1991) . The Met receptor was previously shown to form non-covalent clusters when overexpressed in the absence of HGF (Faletto et al., 1992) , but not much is known about Met homo-or hetero-dimerization.
In this study, we investigated the possible cross-talk between the Met and Ron receptors. We report that both ligand-independent and ligand-dependent heterocomplex formation occurs and Met transphosphorylation leads to reciprocal activation, followed by association with signal transducers. Figure 1 ). This indicates that through the formation of Met/Ron heterodimers reciprocal transphosphorylation on tyrosine residues occurs. As previously described, due to overexpression, both Met and Ron precursors are also tyrosine phosphorylated (Gaudino et al., 1994; Longati et al., 1994) . Using stably transfected NIH3T3 cells, coexpressing a more physiological amount of wild type and kinase inactive receptors, we assessed whether HGF or MSP stimulation aects transphosphorylation between Met and Ron. Figure 2 shows that transphosphorylation of the inactive receptor increased when cells were stimulated with the ligand for the active one. As expected, in these conditions Met and Ron precursors were not tyrosine phosphorylated (Longati et al., 1994; Williams et al., 1999) .
Results

Specific transphosphorylation between
We next investigated the speci®city of transphosphorylation by co-expressing kinase inactive Met and Ron with wild type receptors belonging to dierent families such as ErbB1, ErbB2 and TrkA. Met and Ron were immunoprecipitated with speci®c antibodies and analysed by SDS ± PAGE and Western blotting with anti-phosphotyrosine antibodies. In these conditions Transphosphorylation between Met and Ron is direct and occurs both on the catalytic and docking sites To evaluate whether transactivation between Met and Ron was driven by a direct mechanism or if it was mediated by other transducers associated to the receptor, we co-expressed Ron KD or Met KD with the Met or Ron receptors mutated in the docking site and thus unable to recruit signal transducers (Met Double and Ron Double , see Table 1 ). These Met and Ron mutants were previously shown to be active kinases Iwama et al., 1996) . As described above, lysates were immunoprecipitated with anti-Met or antiRon antibodies and phosphorylation was assessed by Western blotting with anti-phosphotyrosine antibodies. Figure 1 shows that both Met Double and Ron Double mutants were able to transphosphorylate their respective inactive partners, suggesting that the transfer of the phosphate to tyrosine phosphorylation sites does not depend on the presence of transducers associated with the receptor or activated in the downstream cascade of events.
We next mapped the tyrosine residues phosphorylated upon trans-activation of receptors. To this end, we used inactive forms of Met in which the catalytic or Table 1 ). Ron WT was co-expressed with the dierent Met mutants and transphosphorylation was evaluated. Met CS2 mutant, which lacks the major catalytic phosphorylation sites, was previously shown to be inactive (Longati et al., 1994) . Here we show that both Met CS2 and Met KD-CS2 are transphosphorylated by wild type Ron, indicating that the transfer of the phosphate group may occur on the tail. On the other hand, transphosphorylation of the Met KD-Double mutant by the wild type Ron can occur on the catalytic tyrosines. As the Met CS2-Double mutant shows no signi®cant phosphorylation we can conclude that the catalytic and the docking tyrosines are the major transphosphorylation sites (Figure 4) .
We also studied if transphosphorylation of the kinase-de®cient receptor by the active partner results in transducers association. Gab1 represents the major substrate and signaling molecule for Met. The in vitro association of transphosphorylated Met KD with Gab1 was analyzed after co-expression of Met KD with Ron WT or Ron Double in COS cells. Anti-Met immunoprecipitates were incubated with GST-Gab1 fusion protein, extensively washed and analysed by SDS ± PAGE followed by Western blotting with anti-Gab1 antibodies. Gab1 was shown to associate Met KD , indicating that upon transphosphorylation the docking site phosphotyrosines of Met KD are available for interaction with its tranducers ( Figure 5 ). The same conclusions were drawn from the reciprocal experiment performed with Ron KD (data not shown).
Homo-and hetero-dimers of Met and Ron are present on the cell surface
We detected the presence of homodimers by crosslinking experiments in GTL-16 cells that express both Met and Ron. Cells were incubated with cross-linker agents in the presence of radiolabeled speci®c ligand ( 125 I-MSP). Lysates were analysed by immunoprecipitation with anti-Met and anti-Ron antibodies, followed by SDS ± PAGE under non-reducing conditions and autoradiography. Speci®c complexes cross-linked with the radiolabeled ligands were shown corresponding to receptor monomers and dimers ( Figure 6 ). By crosslinking experiments in GTL-16 cells, we assessed if Met and Ron can form heterocomplexes. Cells were treated with a cleavable cross-linker (DTSSP) to stabilize receptor complexes on the cell surface. Lysates were analysed by immunoprecipitation with anti-Met and anti-Ron antibodies and SDS ± PAGE under non-reducing conditions followed by Western immunoblotting. The presence of high molecular weight complexes was detected (Figure 7a and b) . To determine the size of these complexes, we also analysed homodimers of the ErbB1 receptor, expressed in COS cells, induced after EGF stimulation and stabilized by cross-linking. The molecular weight of the ErbB1 dimers is known to be 340 kD. By comparison, the size of the Met/Ron complex was estimated to be around 360 kD, consistent with the combined molecular mass of Met and Ron. The presence of both receptors in the same complex was con®rmed by analysis of the anti-Met and anti-Ron immunoprecipitates under reducing conditions, which allowed cleavage of the cross-linker and resolution of Met and Ron contained in the heterocomplex (Figure  7c and d) .
Transphosphorylation of Ron has a functional role in Met signaling
As mentioned in the introduction, Met promotes scattering, growth and invasion of extracellular matrices in epithelial cells. Constitutive activation of Met by point mutations results in cellular transformation. To assess if Ron plays any role in the cascade of events triggered by Met kinase activation, we co-transfected the kinase inactive Ron with the Met mutants D1228N and M1250T. These substitutions are homologous to the oncogenic mutations found in the Kit and Ret kinases and are referred to here as Met Kit and Met Ret (see Table 1 ) The corresponding Met mutants were previously shown to induce transformation (foci formation) when expressed in NIH3T3 cells Jeers et al., 1998a,b) . As shown in Figure  8a , the expression of Ron KD reduced the number of foci induced by the activating Met mutants, indicating that Met Kit and Met Ret transforming ability is impaired by Ron KD . Dierences in transforming activity did not depend on changes in protein expression. Comparable levels of Met expression were detected in all stable cell lines and the same was observed for Ron (Figure 8b ). It is concluded that the kinase inactive Ron behaves as a dominant negative Met eector.
Discussion
Activation of tyrosine kinase receptors is based on ligand-induced dimerization that favors the juxtaposition of the intracellular kinase domains leading to transphosphorylation. In Met and Ron, the major phosphorylation sites are two tyrosine residues located in the activation loop within the kinase domain and involved in kinase upregulation (Longati et al., 1994 ; Iwama et al., 1996) . Other autophosphorylation sites are localized in the receptor tail and are part of the multifunctional docking site responsible for association with SH2-containing signal transducers Iwama et al., 1996) . Thus, tyrosine phosphorylation enhances the catalytic activity of the kinase (Naldini et al., 1991) and provides docking sites for signal transduction molecules .
The formation of homodimers represents the basic mechanism which induces activation of tyrosine kinase receptors by favoring transphosphorylation events (Heldin, 1995; Weiss and Schlessinger, 1998) . Receptor activation by intermolecular phosphorylation has been described for EGF (Honegger et al., 1989 (Honegger et al., , 1990 and PDGF receptor kinases (Westermark and Heldin, 1989) . In this study, we demonstrate by cross-linking experiments that both Met and Ron receptors form homodimers. The presence of high amounts of receptors on the cell surface (overexpression) favors homodimerization and receptor activation (Heldin, 1995) . This could explain why overexpression induces constitutive activation of Met and Ron kinases in vitro (Giordano et al., 1988b; Gaudino et al., 1994) and in several human tumors (Di Renzo et al., 1995; Natali et al., 1996; Maggiora et al., 1998; Taniguchi et al., 1998) .
The ability to form heterodimers between members of the same receptor family has so far been reported for EGF and PDGF receptors (Wada et al., 1990; Kelly et al., 1991) . This heterodimerization has a great potential in permitting cross-talk and generating signal diversity. The best example is provided by the ErbB receptor family (Peles and Yarden, 1993; Carraway and Cantley, 1994; Pinkas-Kramarski et al., 1996) . In particular, heterodimerization between EGF receptor and ErbB2 and between ErbB2 and ErbB3 has been widely described (Qian et al., 1994; Tzahar et al., 1996) . In some cases, the formation of a heterodimer results in more ecient signaling, as in the case of ErbB2/ErbB3 dimer. ErbB2 by itself is not able to eciently induce PI3-kinase activation (Peles et al., 1992) , but when co-expressed with ErbB3, PI3-kinase activity is strongly increased. This is due to the ecient ErbB2-mediated transphosphorylation of ErbB3, which supplies phosphorylation sites for PI3-kinase (Wallasch et al., 1995) .
By cross-linking experiments we here show formation of heterocomplexes between members of the Met receptor family. Moreover, by co-expression of wild type and inactive kinase mutants of Met and Ron, we demonstrated that phosphorylation occurs in trans. Since the inactive kinase retains the ability to dimerize, the catalytic activity of the receptor is not a requisite for dimerization. This conclusion is in agreement with the data reported by Quian et al. (1994) in the heterodimerization between ErbB1 and ErbB2. We show that HGF or MSP stimulation increases transphosphorylation between Met and Ron, but that formation of complexes can occur even in the absence of the ligand. It is likely that receptor overexpression can bypass the need of the ligand to induce and stabilize dimer formation. Nevertheless, the anity of HGF and MSP for their speci®c receptors may be changed by the presence of heterodimers. The modulation of the ligand anity for the receptor may represent a control mechanism of signaling activation (Pinkas-Kramarski et al., 1998) .
The formation of heterocomplexes and transphosphorylation between Met and Ron can lead to reciprocal regulation of the kinase activity. Ron is less ecient than Met as a kinase (Santoro et al., 1996) , thus, the formation of complexes Met/Ron, resulting in a more ecient Ron transphosphorylation by Met, may lead to a more sustained signal than that induced by the Ron/Ron homodimer. Dierent subsets of transducers may be engaged by the heterodimeric receptor complex, providing a mechanism of ®ne tuning of signal transduction.
A role for either HGF/Met and MSP/Ron pairs in the mouse early embryonic development has been described. Mice lacking either HGF or Met have placental-lethal defect with reduced number of trophoblast cells (Uehara et al., 1995) . Also Ron expression in the trophectoderm of the mouse blastocyst has been described to be essential for early stages of development. Ron 7/7 embryos are viable through the blastocyst stage, but fail to survive the peri-implantation period (Muraoka et al., 1999) . In contrast, the loss of Ron ligand ± MSP ± does not impair embryogenesis and mice can grow to adulthood without obvious phenotypic abnormalities (Bezerra et al., 1998) . These data suggest that whereas the Met pathway strictly requires HGF to be induced, Ron activation can be achieved also in the absence of its speci®c ligand. Here we show that Ron can be phosphorylated through the HGF-mediated activation of Met/Ron heterocomplexes. This provides a mechanism for Ron activation by HGF in the case of MSP de®ciency during embryonic development. The response to HGF and MSP through the activation of Met and Ron is mediated by the same pathways, mainly by Ras and by PI-3 Kinase (Wang et al., 1996; Bardelli et al., 1999) . Met can regulate growth and transformation by activating the MAP kinase cascade through Grb2/Sos/Ras complex whereas the Ron pathway is directed more towards cellular movement and matrix invasion (Santoro et al., 1996; Wang et al., 1997) . When Met and Ron receptors are co-expressed, the formation of heterodimers may balance the activation of Ras and PI-3 kinase pathways. The signal might be shifted towards one or the other, aecting the resulting biological response. In this respect, we show that cross-talk between the inactive kinase Ron and constitutively activated Met mutants results in reduction of their transforming ability. Thus, the inactive kinase Ron exerts a dominant negative eect, decreasing the transmission of the signal by the Met receptor. On the other hand, the activation of both Met and Ron in the heterocomplex may result in a cooperative or synergistic response to their ligands. Cooperation between Met and Ron in inducing the morphogenetic response was described in mouse liver progenitor cells that express both receptors (Medico et al., 1996) . Unregulated expression of both Met and Ron has been reported in human hepatocellular carcinoma . Therefore, the concomitant activation of the two receptors might lead to a synergistic eect and may favor, in pathological conditions, the invasive-metastatic phenotype.
Materials and methods
Reagents, antibodies and cell culture
All reagents used were from Fluka (FlukaChemie AG) and Sigma (Sigma Chemicals Co). Reagents for SDS ± PAGE were from Bio-Rad (Biorad Laboratories). Anti-phosphotyrosine and anti-Gab1 antibodies were purchased from UBI. Anti-EGFR, anti ErbB-2, anti-TrkA and anti-Met polyclonal antibodies were from Santa Cruz Biotechnology. The antiMet monoclonal antibody (DQ13) and the anti-Ron antiserum were obtained as described elsewere (Gaudino et al., 1994; Crepaldi et al., 1994a) . Recombinant HGF and MSP were obtained from baculovirus-infected SF-9 cells as previously described (Naldini et al., 1995; Maggiora et al., 1998) .
GTL16 cells are a clonal cell line derived from a poorly dierentiated gastric carcinoma cell line (Giordano et al., 1988) . COS7 and NIH3T3 cells were purchased from American Type Culture Collection. Cultures of mammalian cells were maintained in DMEM or RPMI supplemented with 10% fetal bovine serum (GIBCO ± BRL Life Technologies). NIH3T3 were maintained in DMEM with 10 or 5% Heat-inactivated Colorado Calf serum (Colorado Serum Company, CO, USA). Cells were maintained at 378C in a humidi®ed atmosphere of 5% CO 2 /air. (Longati et al., 1994; Crepaldi et al., 1994b) . PRC mutations, M1250T and D1228H, were reproduced in the human MET cDNA as described elsewhere (Michieli et al., 1996) . Wild type and mutant RON were sub-cloned into the pBABE vector, which carries the resistance to puromycin (Morgenstern and Land, 1990) .
Transient transfections, immunoprecipitation and Western blotting
An equal amount (10 mg total) of wild type and mutant MET and RON cDNAs were transfected in COS7 cells by DNAcalcium phosphate co-precipitation procedure (Cell Phect Trasfection Kit, Pharmacia). After 96 h of transient transfections, cells were washed twice with cold phosphate-buered saline (PBS) and lysed with EB buer (100 mM Tris pH 7.4, 150 mM NaCl, 5 mM EDTA, 10% glycerol, 1% Triton X-100, 1 mM Sodium Ortho-vanadate) supplemented with a cocktail of protease inhibitors (1 mg/ml aprotonin, 50 mg/ml pepstatin, 500 mg/ml leupeptin, 500 mg/ml soybean trypsin inhibitor). Cell lysates were cleared by centrifugation at 15 000 g for 15 min at 48C, immunoprecipitated for 2 h at 48C with the indicated antibodies. The immunocomplexes were washed four times with EB buer and boiled in Laemmli buer in reducing conditions. Proteins were separated on 7% SDS ± PAGE and transferred to Hybond-ECL membranes (Amersham) by high intensity wet blotting (Millipore). Filters were probed with the appropriate antibodies and speci®c binding was decteted by Enhanced Chemiluminescence System (ECL, Amersham). The same ®lters were treated with a stripping buer (2% SDS, 62.5 mM Tris-HCl pH 6.8 and 100 mM b-mercaptoethanol) at 508C for 30 min, washed and re-probed with indicated antibodies.
HGF and MSP stimulation of NIH3T3 cells
NIH3T3 ®broblasts (3610 5 cells) were transfected by calcium phosphate with 4 mg of the pCEV29.1 vector containing the cDNA encoding the Met protein (wild type or Kinase Dead mutated) and 4 mg of the pBABE vector containing the cDNA encoding the Ron protein (wild type or Kinase Dead mutant) as previously described (Michieli et al., 1994) . 40 mg of calf thymus high molecular weight DNA (Boehringer Mannheim) per 100 mm plate were used as carrier DNA. Stable transfectants were selected with the appropriate selective drug (G418, 800 mg/ml, puromycin, 1.5 mg/ml). Stable NIH3T3 clones were seeded on ®bronectin coated plates and starved in serum-free medium for 24 h, stimulated with 100 ng/ml HGF or 300 ng/ml MSP for 15 min at 378C, washed with cold PBS and lysed in EB buer. Immunoprecipitation with anti-Met or anti-Ron antibodies was performed and samples were analysed by SDS ± PAGE and Western blotting with anti-phosphotyrosine antibodies. After stripping ®lters were re-probed with anti-Ron and anti-Met antibodies.
Radiolabeling of ligands and covalent cross-linking analysis
Supernatant of Sf9 cells infected with a Baculovirus expressing the human MSP was treated with dierent percentage of Ammonium Sulphate. Fractions containing the higher amount of MSP (40 ± 50 and 60%), detected by Western blot techniques, were pooled, dialyzed and puri®ed according to Skeel et al. (1991) . Puri®ed MSP (1 mg) was radiolabled with carrier-free Na 125 I (1 mCi) and IODO-GEN (50 mG/ml, Pierce Chemical Co.) as previously described (Naldini et al., 1995) . For covalent cross-linking analysis, 125 I-MSP was added to monolayers of GTL16 cells on ice for 2 h. Cells were then incubated for 30 min at 228C with the chemical cross-linking reagent BS 3 (1 mM) and the reaction was stopped by the addition of 20 mM Tris-HCl pH 7.4. Cells were then washed twice with cold PBS and lysed with EB buer. After clearing, lysates were immunoprecipitated with anti-Met or anti-Ron antibodies. Immunocomplexes were washed four times with EB buer and were solubilized in boiling Laemmli buer. Samples were analyzed by 5% SDS ± PAGE under non-reducing conditions.
Cross-linking experiments
GTL16 cells seeded in 10 cm plates were incubated with 0.25 mM, 3,3'-dithiobis (sulfo-succinimidylpropionate) (DTSSP, Pierce) in PBS for 30 min at 188C, with occasional rocking of plates. After quenching the cross-linking reaction with 20 mM Tris-HCl pH 7.4, cells were washed twice with cold PBS and lysed with EB buer. Lysates were immunoprecipitated with anti-Met or anti-Ron antibodies and samples were analysed by 5% SDS ± PAGE under nonreducing and reducing conditions followed by Western blotting with anti-Met or anti-Ron antibodies.
Association with Gab1
MET and RON cDNAs were transfected in COS7 cells as described above. After lysis with EB buer, anti-Met immunoprecipitates were extensively washed and incubated with Gab1-GST fusion protein (1 mg of recombinant protein/ ml lysate) for 1 h at 48C. After four washes with EB buer, samples were separated on 8% SDS ± PAGE followed by Western blotting with anti-Gab1 antibodies. After stripping, the ®lter was re-probed with anti-phosphotyrosine and antiMet antibodies.
Focus forming assay
NIH3T3 ®broblasts (3610 5 cells) were transfected by calcium phosphate method as described above with 2 mg of the pCEV29.1 vector containing either no insert or the cDNA encoding the Met PRC mutants and 4 mg of the pBABE vector containing either no insert or the cDNA encoding the Ron Kinase Dead mutant. Two days after transfection cells were split into four plates. Three plates were cultured in DMEM containing 5% HICS and were used for measuring focus formation, the fourth was cultured in DMEM containing 10% HICS and the appropriate selective drugs (G418, 800 mg/ml, puromycin, 1.5 mg/ml) to establish stable transfectants. Foci were scored 3 weeks after transfection following ®xation with paraphormaldehyde and Giemsa staining. Clones resistant to G418 and puromycin were pooled and used for Western blotting analysis to test Met and Ron protein expression.
